BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer

Neoplasma

Volumn 58, Issue 3, 2011, Pages 198-204

  Cvelbar, M ^a,b   Hocevar, M ^a   Vidmar, G ^c,d   Teugels, E ^e  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b Community Health Center Novo mesto ^*  (Slovenia)

^c UNIVERSITY REHABILITATION INSTITUTE   (Slovenia)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

^e Laboratory of Molecular Oncology   (Slovenia)

Author keywords

BRCA1 gene; BRCA2 gene; Breast cancer; Double primary cancer; Ovarian cancer

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE PRIMARY BREAST AND OVARIAN CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; OVARY CANCER; BREAST TUMOR; GENETICS; MIDDLE AGED; MULTIPLE CANCER; MUTATION; OVARY TUMOR; PATHOLOGY; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS;

EID: 79961113537     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_03_198     Document Type: Article

References (25)

1. BECKMANN MW, FASCHING PA, BANI MR, LUX MP. Clinical hereditary syndromes in gynaecology. Gynaecology Forum 2005; 10: 12-17.
2. PAL T, permuth-wey J, BETTS JA, KRISCHER JP, FIORICA J et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005; 104: 2807-2816. doi:10.1002/cncr.21536
3. BERRY DA, PARMIGIANI G, SANCHEZ J, SCHILDKRAUT J, WINER E. Probability of carrying a mutation of breast- ovarian cancer gene BRCA1 based on family history. Journal of National Cancer Institute 1997; 89: 227-238. doi:10.1093/jnci/89.3.227
4. SCHORGE JO, MAHONEY NM, MILLER DS, COLEMAN RL, MULLER CY et al. Germline BRCA1-2 Mutations in Non-Ashkenazi Families with Double Primary Breast and Ovarian Cancer. Gynecologic Oncology 2001; 83: 383-387. doi:10.1006/gyno.2001.6431
5. SHIH HA, NATHANSON KL, SEAL S, COLLINS N, STRETTON MR et al. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clinical Cancer Re- searh 2000; 6: 4259-4264.
6. CVELBAR M, Ursič-Vrščaj M, RAKAR S. Risk factors and prognostic factors in patients with double primary cancer: Epithelial ovarian cancer and breast cancer. European Journal of Gynaecological Oncology 2005; 26: 59-63.
7. Suris-Swartz PJ, SCHILDKRAUT JM, VINE MF, Hertz-Picciotto I. Age at diagnosis and multiple primary cancers of the breast and ovary. Breast Cancer Research and Treatment 1996; 41: 21-29. doi:10.1007/BF01807033
8. FISHMAN A, AVIRAM R, BEYTH Y, BERNHEIM J, ALTARAS M. A second primary malignancy in a cohort of patients with epithelial ovarian cancer - characteristics of diagnosis. European Journal of Gynaecologic Oncology 1998; 19: 280-283.
9. Fishman A, Dekel E, Chetrit A, Lerner-Geva L, Baram A et al. Patients with double primary tumors in the breast and ovary - clinical characteristics and BRCA1-2 mutations status. Gynecologic Oncology 2000; 79: 74-78. doi:10.1006/gyno.2000.5895
10. HOGERVORST FB, CORNELIS RS, BOUT M, VAN VLIET M, OOSTERWIJK JC et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 1995 Jun; 10: 208-12. doi:10.1038/ng0695-208
11. van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, BODMER D et al. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Duch cancer clinic setting. Hum Mutat 2006 Jul; 27: 654-66. doi:10.1002/humu.20340
12. KRAJC M, DE GRÈVE J, GOELEN G, TEUGELS E. BRCA2 founder mutation in Slovenian breast cancer families. European Journal of Human Genetics 2002; 10: 879-882. doi:10.1038/sj.ejhg.5200886
13. [13] Krajc M., Teugels E., Žgajnar J, Goelen G, Bešić N et al. Five reccurent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. http://www.biomedcentral.com/1471-2350/9/83
14. Krajc M, Žgajnar J, Bešić N, Hočevar M, Bilban Jakopin C et al. Genetic counselling and testing in slovenian breast and ovarian cancer families. In: Žgajnar J e tal, eds. Geni in rak-19. onkološki vikend; 2006 May 26-27; Laško, Slovenija. Ljubljana: Kancerološko združenje Slovenskega zdravniškega društva, Onkološki inštitut Ljubljana in Zveza slovenskih društev za boj proti raku; 2006: 48-58.
15. CAMPEAU PM, FOULKES WD, TISCHKOWITZ MD. Hereditary breast cancer: new genetic developments, new therapeutic evenues. Human Genetics 2008; 124: 31-42. doi:10.1007/s00439-008-0529-1
16. RAZIS E, BOUKOVINAS I, XENIDIS N, RAZIS E, Bou-Kovinas I et al. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients. European Journal of Cancer 2007; 43: 443-453. doi:10.1016/j.ejca.2006.09.021
17. WOOSTER R, WEBER B. Breast and Ovarian Cancer. The New England Journal of Medicine 2003; 348: 2339-2347. doi:10.1056/NEJMra012284
18. MENKISZAK J, GRONWALD J, GÓRSKI B, BYRSKI T, HUZARSKI T et al. Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2. European Journal of Gynaecologic Oncology 2004, 25: 99-100.
19. PRAT J, RIBÉ A, GALLARDO A. Hereditary ovarian cancer. Human Pathology 2005; 36: 861-870. doi:10.1016/j.humpath.2005.06.006
20. BOYD J, SONODA Y, FEDERICI M, BOGOMOLNIY F, RHEI E et al. Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer. JAMA 2000; 283: 2260-2265.
21. BECKMANN MW, FASCHING PA, BANI MR, LUX MP. Clinical hereditary syndromes in gynaecology. Gynaecology Forum 2005; 10: 12-17.
22. WEITZEL JN, ROBSON M, PASINI B, MANOUKIAN S, STOPPA-LYONNET D et al. A comparison of bilateral breast cancers in BRCA carriers. Cancer Epidemiology, Biomarkers & Prevention 2005; 14:1534-1538. doi:10.1158/1055-9965. EPI-05-0070
23. SHAHEDI K, EMANUELSSON M, WIKLUND F, Gron-Berg H. High risk of contralateral breast carcinoma in women with hereditaty7familial non-BRCA1/BRCA2 breast carcinoma. Cancer 2006; 106: 1237-1242. doi:10.1002/cncr.21753
24. METCALFE K, LYNCH HT, GHADIRIAN P, TUNG N, OLLIVOTTO I et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology 2004; 22: 2328-2335. doi:10.1200/JCO.2004.04.033
25. VERONESI A, DE GIACOMI C, MAGRI MD, LOMBARDI D, ZANETTI M et al. Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases. BMC Cancer 2005, 5: 70. http://www.biomedcentral.com/1471-2407/5/70